125 related articles for article (PubMed ID: 9246269)
1. The ocular presentation of neurofibromatosis 2.
Ragge NK; Baser ME; Riccardi VM; Falk RE
Eye (Lond); 1997; 11 ( Pt 1)():12-8. PubMed ID: 9246269
[TBL] [Abstract][Full Text] [Related]
2. Ocular abnormalities in neurofibromatosis 2.
Ragge NK; Baser ME; Klein J; Nechiporuk A; Sainz J; Pulst SM; Riccardi VM
Am J Ophthalmol; 1995 Nov; 120(5):634-41. PubMed ID: 7485365
[TBL] [Abstract][Full Text] [Related]
3. Retinal changes associated with neurofibromatosis 2.
Meyers SM; Gutman FA; Kaye LD; Rothner AD
Trans Am Ophthalmol Soc; 1995; 93():245-52; discussion 252-7. PubMed ID: 8719681
[TBL] [Abstract][Full Text] [Related]
4. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
5. Astrocytic hamartoma of the optic disc and multiple café-au-lait macules in a child with neurofibromatosis type 2.
Sachdeva R; Rothner DA; Traboulsi EI; Hayden BC; Rychwalski PJ
Ophthalmic Genet; 2010 Dec; 31(4):209-14. PubMed ID: 21067482
[TBL] [Abstract][Full Text] [Related]
6. [Retinal Astrocytic Hamartoma in Neurofibromatosis Type 2 - Metaanalysis and a Case Report].
Starosta DA; Lorenz B
Klin Monbl Augenheilkd; 2018 Mar; 235(3):290-300. PubMed ID: 29534265
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
9. [NF2: ocular, neural and genetic manifestations].
Feucht M; Mautner VF; Richard G
Klin Monbl Augenheilkd; 2005 Apr; 222(4):312-6. PubMed ID: 15844040
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
Bosch MM; Boltshauser E; Harpes P; Landau K
Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
[TBL] [Abstract][Full Text] [Related]
11. Ocular alterations in alopecia areata.
Recupero SM; Abdolrahimzadeh S; De Dominicis M; Mollo R; Carboni I; Rota L; Calvieri S
Eye (Lond); 1999 Oct; 13 ( Pt 5)():643-6. PubMed ID: 10696317
[TBL] [Abstract][Full Text] [Related]
12. Ocular findings associated with neurofibromatosis type II.
Kaye LD; Rothner AD; Beauchamp GR; Meyers SM; Estes ML
Ophthalmology; 1992 Sep; 99(9):1424-9. PubMed ID: 1407974
[TBL] [Abstract][Full Text] [Related]
13. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis 2 leads to choroidal hyperfluorescence in fluorescein angiography.
Feucht M; Richard G; Mautner VF
Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):949-53. PubMed ID: 17186263
[TBL] [Abstract][Full Text] [Related]
15. [Early type 2 neurofibromatosis and congenital retinal hamartoma].
Hérissé AL; Poirée M; Boyer C; Soler C; Leloutre B; Geoffray A
Arch Pediatr; 2015 Jul; 22(7):729-32. PubMed ID: 26047750
[TBL] [Abstract][Full Text] [Related]
16. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders.
Feucht M; Griffiths B; Niemüller I; Haase W; Richard G; Mautner VF
Acta Ophthalmol; 2008 Dec; 86(8):882-6. PubMed ID: 18976311
[TBL] [Abstract][Full Text] [Related]
18. [Neurofibromatosis type 2].
Schimmel LJ; Keyser A
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):639-43. PubMed ID: 9190540
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
20. Lens opacities in neurofibromatosis 2: further significant correlations.
Bouzas EA; Freidlin V; Parry DM; Eldridge R; Kaiser-Kupfer MI
Br J Ophthalmol; 1993 Jun; 77(6):354-7. PubMed ID: 8318482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
